Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis

AD Salama, T Chitnis, J Imitola, MJI Ansari… - The Journal of …, 2003 - rupress.org
AD Salama, T Chitnis, J Imitola, MJI Ansari, H Akiba, F Tushima, M Azuma, H Yagita…
The Journal of experimental medicine, 2003rupress.org
Experimental autoimmune encephalomyelitis (EAE) is mediated by autoantigen-specific T
cells dependent on critical costimulatory signals for their full activation and regulation. We
report that the programmed death-1 (PD-1) costimulatory pathway plays a critical role in
regulating peripheral tolerance in murine EAE and appears to be a major contributor to the
resistance of disease induction in CD28-deficient mice. After immunization with myelin
oligodendrocyte glycoprotein (MOG) there was a progressive increase in expression of PD-1 …
Experimental autoimmune encephalomyelitis (EAE) is mediated by autoantigen-specific T cells dependent on critical costimulatory signals for their full activation and regulation. We report that the programmed death-1 (PD-1) costimulatory pathway plays a critical role in regulating peripheral tolerance in murine EAE and appears to be a major contributor to the resistance of disease induction in CD28-deficient mice. After immunization with myelin oligodendrocyte glycoprotein (MOG) there was a progressive increase in expression of PD-1 and its ligand PD-L1 but not PD-L2 within the central nervous system (CNS) of mice with EAE, peaking after 3 wk. In both wild-type (WT) and CD28-deficient mice, PD-1 blockade resulted in accelerated and more severe disease with increased CNS lymphocyte infiltration. Worsening of disease after PD-1 blockade was associated with a heightened autoimmune response to MOG, manifested by increased frequency of interferon γ–producing T cells, increased delayed-type hypersensitivity responses, and higher serum levels of anti-MOG antibody. In vivo blockade of PD-1 resulted in increased antigen-specific T cell expansion, activation, and cytokine production. Interestingly, PD-L2 but not PD-L1 blockade in WT animals also resulted in disease augmentation. Our data are the first demonstration that the PD-1 pathway plays a critical role in regulating EAE.
rupress.org